ReleaseWire Connect

The global Automotive HVAC market provides for the heating, cooling, and ventilation of the cabin of a vehicle. The global HVAC market is expected to grow at a CAGR of 18.5% till 2015 with a sales of 144.3 million units. Increased cabin comfort in the automotive market is a value addition service that manufacturers cannot ignore. This is a key driver for the growth of the market as it is estimated that global auto sales would reach 85 million units by the end of 2014. Most automotive users need HVAC for comfortable travel; therefore, the Automotive HVAC market can expect good sales volumes in the next five years.

Food and beverage enzymes are highly selective chemical catalysts that initiate metabolic reaction within unripe fruit and other food materials. The demand for enzyme consumption is expected to rise to 6.8 percent annually to $8.0 billion in 2015. These food and beverage enzyme include carbohydrates, protease and lipase enzymes. The global Food enzyme market is expected to grow to $2.2 billion by 2018. Increase in demand for processed food products drive the food enzyme market. U.S. is one of the largest players in the food enzyme followed by China. Counterfeiting of food packaging decreases the growth for food enzyme. Food processing companies such as Novozymes A/S, Palsgaard A/S, Purac Biochem B.V. are facing problems due to counterfeiting activities. The problems faced by food enzyme manufacturing companies are expected to be resolved as the governments are taking initiatives to overcome the restraints. This report provides market forecast information about current trends and future expected growth in food enzyme market. It also provides current market trends and transition of these trends in future.

Wearable medical devices are handheld monitoring tools used in identification and monitoring of disease. Due to the Increase in chronic diseases, patients are opting home healthcare as a cost effective and efficient way of treatment, rather than hospital services. Medical device market accounted for $240 billion in 2013. However, increase in incidence of chronic diseases restricts the growth of Wearable medical device market. Neurological diseases in people have increased to 7.2% in urban areas, causing hurdles for monitoring through wearable medical devices.

The global medical automation technologies market provides various automated services in health monitoring, prescriptions, therapeutics etc. The global medical technologies market revenue stood at $300 billion in 2011 and it is expected to grow at a CAGR of 7% by 2016. The Medical automation technologies market is expected to have a significant market share as highly automated and sophisticated services are available in the market. Venture capitalists are investing in the market to boost the development of medical automation, which is a key driver for the market. For example, Google started a healthcare company, Calio, and is now developing smart contact lens for monitoring diabetes.

Neurovascular disease is a condition caused to nervous tissues vascular structure, neurons and blood vessels that leads to serious brain damages such as stroke, and cerebral hemorrhage. The global market for central nervous system disease was accounted to approximately $78 billion in 2010. Neurovascular disease market is mainly driven by the increase in number of patients suffering from neurological diseases. According to University of California, San Francisco (USCF), there are approximately 600,000 people suffering from stroke, out of which 10% are recovered. Almost 30% patients die due to stroke, and 60% of the patients remain disabled. The cost of care for these 60% patients accounted to approximately $8 billion. Cost of neurological disease treatment is lowering the growth for neurological disease. Companies are conducting clinical trials to commercialized cost effective therapies through mergers and acquisitions.

Biomaterials are artificially derived natural materials that are used in medical applications such as organ transplantation and replacement of tissues. The global market for medical devices was accounted to $240 billion in 2013. This shows the potential for growth of biomaterial market. Increase in aging population is the major driver for biomaterial market. Due to the increase in number of aging patients, the usage of biomaterial in wound healing, plastic surgery, neurology and tissue engineering is increasing. According to the Society for Biomaterials, there are more than 5000 novel research article published every year for improved wound care techniques and surgical devices. Biomaterials market growth is hindered by certain factors such as inflammatory responses and strict government regulations for commercialization. In 1999, Government of Norway conducted "Dental Biomaterial- Adverse Reaction Unit" activity to control and evaluate adverse implication in dental fields.

Anti fungal agent is a drug that detects and eliminates fungal pathogens from foreign body with minimal toxic side effects to the body. The global market for anti fungal agents is expected to reach approximately $102 billion by 2015. The Anti fungal agent market growth is increasing due to rise in number of patients suffering from hygiene related diseases in developing countries and some of the developed countries.

Optical imaging is a fiber optic and photonics based non-invasive technique that enables accurate viewing of organs, tissues and even molecules. The global Optical imaging technology market comprises Photo-Acoustic Tomography (PAT), Optical Coherence Tomography (OCT), Near-Infrared Spectroscopy (NIRS), and Hyper-Spectral Imaging (HSI). This technology finds primary application in clinical research and pathology for disease diagnosis and treatment. Optical imaging market was valued $915.75 million in 2012 and is expected to grow at a CAGR of 12.2% during 2013-2020. In comparison to conventional radiological technologies, optical imaging has led to significant reduction in exposure to harmful rays. As the technique involves a non-invasive and no ionization process of imaging, it offers higher safety and allows repeated imaging to track the progression of disease or effectiveness of the treatment. Growing healthcare concern throughout the globe is a largely impacting driver of the market.

Microscopy is the technology that focuses on magnifying the images of small biological specimen. Automated microscopy is an advance technology that uses advance monitoring techniques such as atomic force microscopy (afm) and raman confocal systems, that enhance monitoring of biological specimen. Global microscopy market was accounted to $2.7 billion in 2010. Development of user friendly and less complex microscope are driving the growth for automated microscopy market. The global market for automated microscopy is dominated by higher cost restraint. The high cost required for digital setup is decreasing the growth for automated microscopy market. However, increase in technological advancements will influence the cost of the equipments, which will affect the price of the microscopy setup. The cost for an average automated microscope varies from $5,000-$15,000.

Medical implants are artificial devices that are used to replace damaged or missing biological structures. The global revenue generated by medical device manufacturing companies is over $200 billion, and more than $85 billion is accounted to the U.S. based medical device companies. The Medical implants market is driven by an increase in health needs of old age people, and advancement in medical technologies. According to the WHO, there are more than 1000 million old age people in the world, out of which 700 million are from developing countries. Increase in demand for reconstruction of joints, replacement of ophthalmic and dental market is expecting more growth in medical implant market. However, high cost of treatment and unavailability of expertise are decreasing the demand for medical implant market.